FONR vs. VANI, OM, ELMD, HYPR, RMTI, CUTR, PXDT, ECOR, POCI, and MOVE
Should you be buying FONAR stock or one of its competitors? The main competitors of FONAR include Vivani Medical (VANI), Outset Medical (OM), Electromed (ELMD), Hyperfine (HYPR), Rockwell Medical (RMTI), Cutera (CUTR), Pixie Dust Technologies (PXDT), electroCore (ECOR), Precision Optics (POCI), and Movano (MOVE).
Vivani Medical (NASDAQ:VANI) and FONAR (NASDAQ:FONR) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, valuation, community ranking, media sentiment, analyst recommendations, profitability, institutional ownership and risk.
FONAR has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than FONAR, indicating that it is currently the more affordable of the two stocks.
FONAR received 168 more outperform votes than Vivani Medical when rated by MarketBeat users. However, 100.00% of users gave Vivani Medical an outperform vote while only 73.48% of users gave FONAR an outperform vote.
In the previous week, Vivani Medical and Vivani Medical both had 2 articles in the media. Vivani Medical's average media sentiment score of 1.13 beat FONAR's score of 0.50 indicating that FONAR is being referred to more favorably in the news media.
Vivani Medical has a beta of 3.26, indicating that its stock price is 226% more volatile than the S&P 500. Comparatively, FONAR has a beta of 1.12, indicating that its stock price is 12% more volatile than the S&P 500.
FONAR has a net margin of 12.63% compared to FONAR's net margin of 0.00%. Vivani Medical's return on equity of 8.47% beat FONAR's return on equity.
6.8% of Vivani Medical shares are held by institutional investors. Comparatively, 50.6% of FONAR shares are held by institutional investors. 55.6% of Vivani Medical shares are held by company insiders. Comparatively, 2.2% of FONAR shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Summary
FONAR beats Vivani Medical on 10 of the 13 factors compared between the two stocks.
Get FONAR News Delivered to You Automatically
Sign up to receive the latest news and ratings for FONR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding FONR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
